BiondVax Pharma (BVXV) Reports Q2 Loss of NIS0.05/Share
Tweet
Share
E-mailGet Alerts BVXV Hot Sheet
Join SI Premium – FREE
BiondVax Pharma (NASDAQ: BVXV) reported Q2 EPS of (NIS0.05), versus (NIS0.02) reported last year.
For earnings history and earnings-related data on BiondVax Pharma (BVXV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- nCino, Inc. (NCNO) Reports Q2 EPS of $0.05, Offers Guidance
- IMF chief says global economy weathered Iran war shock well
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
